The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Multiplex layered immunohistochemistry to predict responseĀ of HER2-positive breast cancer patients to trastuzumab therapy.
Soon Sik Park
Employment or Leadership Position - 20/20 GeneSystems
Research Funding - 20/20 GeneSystems
John Williams Gillespie
Employment or Leadership Position - 20/20 GeneSystems
Research Funding - 20/20 GeneSystems
Bill James
Employment or Leadership Position - 20/20 GeneSystems
Stock Ownership - 20/20 GeneSystems
Research Funding - 20/20 GeneSystems
Michael Lebowitz
Employment or Leadership Position - 20/20 GeneSystems
Research Funding - 20/20 GeneSystems